Home Tags CAR-T
This strategic partnership between Amrita Hospital, Faridabad and IIT Bombay incubated company will ensure that patients across all segments benefit from this life-saving advanced medicine
Increased investments likely to boost the research and production capabilities and eventually makes the therapies affordable to those in need, says GlobalData, a leading data and analytics company.
According to GlobalData forecasts, the Novartis CAR-T therapy, Kymriah is expected to hit over $1billion sales revenue by 2023 in the US alone......……….
A fairly comprehensive study reported in February 2018 on the Health Affairs Blog claims that Novartis could lower the price of Kymriah by two-thirds and still achieve a profit..................